VSI II made its first investment by acquiring 50% of SAÚDE VIÁVEL GROUP, leading a co-investment with HERMES


Vallis Sustainable Investments II informs that it has completed its first investment with the acquisition of 50% of the share capital of Saúde Viável Group, leading a co-investment with the British Private Equity, Hermes GPE.

Saúde Viável is the largest clinical Group exclusively dedicated to the Diagnosis, Treatment and Research in Health and Hair Transplantation, with facilities in Lisbon, Porto, Vilamoura and Madrid

In the last five years, Saúde Viável grew at an average annual rate above 50%, reaching a turnover close to 17 million Euros in 2018, having performed over 30,000 hair transplants since its inception and conquered the confidence of its patients.

Founded in 2009, the Group has more than 200 employees, including Doctors, Nurses, Clinical Advisers and Researchers, with an Academy for the specific and advanced training of its professionals.

Saúde Viável has a Research Department in Robotics and Cellular Therapies in collaboration with I3S – Institute of Research and Innovation in Health of the University of Porto, through which research is carried out on Stem Cells of follicular units aiming scientific advances in the treatment for the resolution of baldness.

Saúde Viável, in partnership with one of the greatest icons in world sport, synonymous with effort, dedication and dynamism – Cristiano Ronaldo – started its international expansion in March 2019, having opened its first clinic in Madrid, with the brand Insparya, which has already conquered the market leadership in the number of hair transplants performed in this period. Cristiano Ronaldo’s personal interest in the health area, as well as the recognition of the quality of the clinical project, were at the origin of this partnership with Saúde Viável.

With this partnership between Vallis Sustainable Investments II Fund, HERMES GPE and its Founder and CEO, Paulo Ramos, who will keep 50% of the share capital, Saúde Viável Group will pursue an international expansion strategy based on the opening of clinics in the main European cities, designed to achieve world leadership in the sector, always focusing on the high quality of clinical service provided to each patient.


About Saúde Viável Group:

Saúde Viável Group (SVG) is a leading group specialized in the diagnosis and treatment of alopecia, operating in Lisbon, Porto, Algarve and Madrid.



About Vallis Sustainable Investments II Fund:

The Fund Vallis Sustainable Investments II, regulated by the CMVM, is the second Private Equity growth-oriented investment fund sponsored by Vallis Capital Partners., with a target fund size of 150 million Euros. This Fund, launched in 2019, succeeds Vallis Sustainable Investments I, with a capitalization of 75 million Euros.

The Fund acts in accordance with Socially Responsible criteria, prioritizing in its investment strategy, companies placed in market segments with high growth potential.

VSI II funds partially benefit from the financial backing of the European Union under the Equity Facility for Growth established under Regulation (EU) No 1287/2013 of the European Parliament and the Council establishing a Programme for the Competitiveness of Enterprises and Small and Medium-sized Enterprises (COSME), and of Fundo de Capital e Quase Capital (FC&QC) and Fundo de Fundos para a Internacionalização (FFI), both managed by IFD – Instituição Financeira de Desenvolvimento, S.A.



About Hermes GPE:

Hermes GPE is a UK-based Private Equity firm focused on fund investments and co-investments in buyouts and growth businesses, managing $6 bn of assets via managed accounts, pooled funds and side cars, working in partnership with a wide range of LP clients.